News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
184 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (2794)
February (3040)
March (3567)
April (3109)
May (3537)
June (3472)
July (2691)
August (3172)
September (3382)
October (3298)
November (3733)
December (2588)
Day
1 (168)
2 (106)
5 (159)
6 (162)
7 (183)
8 (142)
9 (138)
12 (184)
13 (189)
14 (131)
15 (148)
16 (109)
17 (5)
19 (154)
20 (128)
21 (136)
22 (125)
27 (1)
28 (160)
29 (60)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
5
6
7
8
9
12
13
14
15
16
17
19
20
21
22
27
28
29
FDA
FDA Approves Endo Pharmaceuticals’ Crush-Resistant Opana ER
December 12, 2011
·
4 min read
Drug Development
Immunomedics, Inc. Reports Subcutaneous Injections of Low-Dose Veltuzumab Produced High Rates of Response in Relapsed Immune Thrombocytopenia
December 12, 2011
·
1 min read
Deals
Cubist Pharmaceuticals, Inc. Completes Acquisition of Adolor Corporation
December 12, 2011
·
1 min read
Deals
Sagentia Cashes in on Sphere Medical IPO and Hoists Profits
December 12, 2011
·
1 min read
Biotech Beach
Optimer Pharmaceuticals, Inc. Release: The European Commission (EC) Grants Marketing Authorization for DIFICLIR(TM) (fidaxomicin) Tablets for Treatment of Clostridium difficile Infections
December 12, 2011
·
5 min read
Drug Development
Ariad Pharmaceuticals, Inc. Blood-Cancer Drug’s 46% Success Rate May Prompt FDA Approval Boost
December 12, 2011
·
9 min read
Business
Xeris Pharmaceuticals Closes US$1.5 Million Series A Financing with Central Texas Angel Network
December 12, 2011
·
1 min read
Business
Acetylon Pharmaceuticals Announces Addition of Catherine A. Wheeler MD as Vice President Clinical Development
December 12, 2011
·
1 min read
BioMidwest
3M Company Food Safety Unveils Innovative Molecular Detection System for Dangerous Foodborne Pathogens
December 12, 2011
·
1 min read
Business
Mazor Robotics Purchase Agreement for the First Renaissance System in the Houston, Texas Market
December 12, 2011
·
1 min read
Previous
17 of 19
Next